Leading the life sciences industry
Discover the 150+ academic medical centers, commercial labs, incubators, accelerators, and programs and services leading life sciences in New York State.
Funding
Investing in innovation
Careers
Your future starts here
The Latest
SBIR-STTR Reauthorized through 2031
“Driven by innovative startups, the United States leads the world in scientific breakthroughs and transformative technology – and thanks to this law, SBIR and STTR will continue to power entrepreneurs who are building the industrial base of the future,” said Administrator Kelly Loeffler. “For decades, these cross-agency programs have enabled small, innovative businesses to take…
‘Can it actually deliver?’: Why Big Pharma is making the leap to the quantum realm
Artificial intelligence has long been seen as a way to supercharge drug development. But a whole new frontier of computing is opening up at cutting-edge labs around the globe—and Big Pharmas are getting in on the action.
Research revealing how the brain flushes waste named STAT Madness Editors’ Pick
University of Rochester Neuroscientist Maiken Nedergaard’s research was selected by editors for its innovation, rigor, and potential impact from among 64 teams that competed in the month-long, bracket-style STAT Madness tournament and celebration of biomedical research. More than a decade after Nedergaard’s discovery of the glymphatic system highlighted the importance of sleep for brain health,…
2026 Report: Upstate New York Start-up Ecosystem
Upstate Capital has launched a new Upstate New York Startup Ecosystem Report, available through the InvestNY platform. The InvestNY platform, sponsored by NY Ventures, NYSTAR, and the Griffiss Institute, provides a data-driven view of startups, investment activity, and key sectors across Upstate New York.
SBIR / STTR reauthorization is passed by Congress
LIFE SCIENCES IN NEW YORK
Where science and opportunity come together
New York’s life science sector has attracted unprecedented investment, expanded research clusters across the state, and nurtured the growth of early-stage companies.
70,000
LIFE SCIENCES JOBS
25%
CLINICAL TRIALS IN THE U.S.
60%
PHARMACEUTICAL HEADQUARTERS